US2013324759A1PendingUtilityA1
Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
Est. expirySep 22, 2020(expired)· nominal 20-yr term from priority
A61P 43/00A61P 5/00A61P 9/00A61P 3/10A61P 39/06A61P 9/10A61P 5/06A61P 39/00A61P 37/06A61P 25/04A61P 25/36A61P 25/32A61P 25/22A61P 25/30A61P 25/00A61P 25/28A61P 25/24A61P 29/00A61P 25/20A61P 25/16C07C 233/49A61P 1/00C07C 229/24C07C 229/36C07C 69/67A61P 23/00C07H 13/04C07C 229/22C07C 69/675A61P 1/04C07C 233/47
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides compositions comprising at least one GHB moiety bonded to at least one physiologically compatible carrier molecule. The compositions can enhance the uptake of the drug, deliver effective therapeutic doses in a time-delayed fashion, or can target specific organs.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A compound of the formula (II):
(R 1 O(CH 2 ) 3 CO 2 ) m (ROC(O)(CH 2 ) 3 OC(O)) q —(X)—(Y) n —(Z) n —(CO 2 (CH 2 ) 3 CO 2 R) p (O 2 C(CH 2 ) 3 OR′) k (II)
wherein R′ is H or a hydroxyl-protecting group, R is H, (C 1 -C 4 )alkyl or benzyl, X and Z are each residues of a hydroxy group-containing amino acid or a bis(carboxy)amino acid, Y is a moiety covalently linking X and Z, n is 0-1, m and k are 0 to the number of available hydroxy groups on the amino acids X and Z; q and p are 0 to the number of available CO 2 groups on amino acids X and Z, with the proviso that both m and q and both p and k are not zero, or a pharmaceutically acceptable salt thereof.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.